Clinical trial
Combination Chemotherapy in Treating Patients With Esophageal Cancer
NCT00041262 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00041262 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Esophageal Cancer |
| Official title | A Prospective Randomized Trial Comparing Standard Chemotherapy Followed By Resection Versus Infusional Chemotherapy In Patients With Resectable Adenocarcinoma Of The Oesophagus |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, epirubicin hydrochloride, fluorouracil, conventional surgery, neoadjuvant therapy |
| Enrollment | 1,300 |
| Start date | Nov 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 12, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: